Patent · US Active

Compounds, compositions and methods

US9150564B2 · kind B2 · utility

25Cited by
40References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 18, 2014
Grant dateOct 6, 2015
Priority date
Expiry dateSep 18, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.